News: Biocon drug Itolizumab has been approved by the Drugs Controller General of India(DCGI) for treating moderate to severe Covid-19 patients. Facts: Itolizumab: It is a monoclonal antibody drug manufactured by Biocon for the treatment of severe chronic plaque psoriasis. Monoclonal antibodies are lab-made proteins that act like human antibodies in the immune system and… Continue reading Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients
Tag: Itolizumab
Search Articles
Latest Articles
- Issue with fiscal transfers in India
- Affirmative Action in India- Constitutional Provisions, Implementation Challenges, and Political Debates
- Generative AI impacting cybersecurity
- How India’s agricultural exports fell
- UPSC IFoS 2023 CutOff PDF for Prelims Mains and Final List Released
- Detailed Preparation Strategy For UPSC CSE Prelims, Mains, Answer Writing, Notes Making, Etc. by Rupal Rana, AIR 26, 2023,
- [Download] New and Improved 9 PM UPSC Weekly Compilation – May 2024 – 1st week
- UPSC Prelims Marathon 10th May – Bilateral and Regional Groupings – 2024
- [Download] New 10 PM Weekly Compilation – May 2024 – 1st week
- 10 PM UPSC Current Affairs Quiz 9 May, 2024